{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:37:44Z","timestamp":1775914664013,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.meegid.2021.104781","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:23:24Z","timestamp":1614169404000},"page":"104781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of HBeAg status on immune recovery in HIV\/HBV co-infected patients after highly active antiretroviral therapy"],"prefix":"10.1016","volume":"91","author":[{"given":"Yuan","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiZi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FengYu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2021.104781_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2012.09.017","article-title":"Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy","volume":"58","author":"Cheng","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104781_bb0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/infdis\/jiu119","article-title":"Lipopolysaccharide, immune activation, and liver abnormalities in HIV\/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy","volume":"210","author":"Crane","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104781_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee and European Association for the Study of the L. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104781_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2010.12.030","article-title":"Natural history of chronic hepatitis B in Euro-Mediterranean and African countries","volume":"55","author":"Hadziyannis","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104781_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2021.104781_bb0030","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMp1201796","article-title":"HIV-HBV coinfection--a global challenge","volume":"366","author":"Kourtis","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meegid.2021.104781_bb0035","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2009.03.006","article-title":"Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a","volume":"136","author":"Marcellin","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2021.104781_bb0040","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/QAD.0b013e328349bbf3","article-title":"Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV\/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa","volume":"25","author":"Matthews","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.meegid.2021.104781_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","article-title":"Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma","volume":"47","author":"Sun","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2021.104781_bb0050","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/infdis\/jit351","article-title":"Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study","volume":"208","author":"Wandeler","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104781_bb0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/vim.2010.0042","article-title":"Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines","volume":"23","author":"Wu","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.meegid.2021.104781_bb0060","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","article-title":"HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010\u201312: a retrospective observational cohort study","volume":"14","author":"Zhang","year":"2014","journal-title":"Lancet Infect. Dis."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:48:29Z","timestamp":1761576509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":12,"alternative-id":["S1567134821000782"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104781","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HBeAg status on immune recovery in HIV\/HBV co-infected patients after highly active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104781"}}